Synopsys, Inc. $SNPS Stock Holdings Raised by Montrusco Bolton Investments Inc.

Montrusco Bolton Investments Inc. increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 29.0% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 537,155 shares of the semiconductor company’s stock after acquiring an additional 120,637 shares during the period. Synopsys makes up approximately 3.0% of Montrusco Bolton Investments Inc.’s holdings, making the stock its 10th largest holding. Montrusco Bolton Investments Inc. owned about 0.29% of Synopsys worth $258,560,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in SNPS. Alpine Bank Wealth Management boosted its stake in shares of Synopsys by 89.3% in the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after purchasing an additional 25 shares during the period. TFC Financial Management Inc. boosted its position in Synopsys by 1,250.0% in the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after buying an additional 50 shares during the last quarter. Millstone Evans Group LLC acquired a new stake in shares of Synopsys during the third quarter valued at about $27,000. SOA Wealth Advisors LLC. purchased a new stake in shares of Synopsys during the third quarter worth about $28,000. Finally, McIlrath & Eck LLC acquired a new position in shares of Synopsys in the third quarter worth about $29,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Insider Buying and Selling at Synopsys

In related news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Janet Lee sold 250 shares of the business’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the transaction, the insider directly owned 11,959 shares of the company’s stock, valued at $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 4,157 shares of company stock valued at $1,945,036. Corporate insiders own 0.62% of the company’s stock.

Analyst Ratings Changes

SNPS has been the subject of a number of recent analyst reports. Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a research report on Thursday, January 22nd. The Goldman Sachs Group set a $600.00 price target on shares of Synopsys and gave the stock a “buy” rating in a research note on Wednesday. Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and reduced their price objective for the company from $525.00 to $500.00 in a research note on Monday, December 8th. Finally, Rosenblatt Securities reissued a “buy” rating and issued a $560.00 target price on shares of Synopsys in a research report on Friday, February 20th. Nine equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $547.00.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Q1 results beat consensus — revenue jumped ~65.6% YoY to $2.409B and non‑GAAP EPS of $3.77 topped estimates; company reiterates full‑year revenue midpoint and provided robust FY and Q2 EPS ranges. Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
• Positive Sentiment: Board authorized a replenishment of the repurchase program (up to $2.0B), supporting shareholder returns and offsetting some integration anxieties. Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
• Positive Sentiment: Some analysts remain constructive — Morgan Stanley maintained a Buy and analysts call out solid earnings quality and IP trajectory as catalysts. Synopsys: Strong Earnings Quality … Support Buy Rating
• Neutral Sentiment: Notable option activity — unusually large call buying suggests elevated speculative interest/positioning into or after the print (could magnify intraday moves).
• Negative Sentiment: Guidance and China exposure concerns: Reuters reports Synopsys flagged a more muted near‑term outlook tied to China export restrictions and macro uncertainty, which pressured the stock despite the beat. Synopsys forecasts muted quarter on China export restrictions, shares fall
• Negative Sentiment: Debt & integration risk from the large acquisition remains in focus — coverage highlights ~$13.5B in debt and questions about digesting the multibillion acquisition, keeping some investors cautious. Synopsys Carries $13.5 Billion in Debt Into Its Most Consequential Earnings Yet
• Negative Sentiment: Market reaction: several reports note SNPS “slid” despite the beat — investors appear to be weighing forward risks (China, deal debt/integration) more heavily than the quarter’s upside. Synopsys slides despite Q1 results demonstrating 65% revenue surge

Synopsys Stock Performance

Shares of NASDAQ SNPS opened at $449.17 on Thursday. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The firm’s 50-day moving average price is $472.85 and its two-hundred day moving average price is $479.02. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The stock has a market capitalization of $86.04 billion, a P/E ratio of 56.22, a P/E/G ratio of 3.67 and a beta of 1.12.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, topping analysts’ consensus estimates of $3.56 by $0.21. The business had revenue of $2.41 billion for the quarter, compared to analysts’ expectations of $2.39 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The business’s quarterly revenue was up 65.6% on a year-over-year basis. During the same period in the prior year, the firm earned $3.03 EPS. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, sell-side analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.